JPRN-UMIN000006983已完成2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinoma - Phase II study of S-1continuation maintenance therapy following CBDCA/S-1 in lung squamous cell carcinoma NSCLC :S-COT
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who received previous treatment with the 5-FU 2) Patients who is contraindicated to administration of CBDCA and S-1 3) Patients with a history of the drug hypersensitivity 4) Patients with symptomatic metastases to brain 5) Uncontrolled massive pleural effusion, ascitic fluid and pericardial fluid retention case 6) Patients with watery diarrhea 7) Patients with serious complications 8) Patients with active concomitant malignancy 9) Patients with HBs antigen-positive or with HCV antibody-positive 10) Patients who uses flucytosine 11) Women with the pregnant possibility, a pregnancy or lactation and men with willing to get pregnant 12) Patients who were complicated with mental disease or neurologic manifestation, and it is judged that the participation in study is difficult 13) Any other cases who are regarded as inadequate for study enrollment by the investigator.
研究者
相似试验
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20
已完成
2 期
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
已完成
2 期
A Phase II Study of Combination Chemotherapy using TS-1 and Cisplatin with Concurrent Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung CancerJPRN-UMIN000001370West Japan Oncology Group55